Priority Review

October 19, 2017October 19, 2017

FDA Giving Priority Review to Gilotriftm as Treatment for Rare Form of Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration is giving priority review to Boehringer Ingelheim’s request that the agency consider approving Gilotriftm (afatinib) for an additional category of lung cancer patients. Gilotriftm is already approved ... Read more

April 13, 2016April 13, 2016

Genentech’s Atezolizumab for Non-Small Cell Lung Cancer Gets FDA Nod for BLA and Priority Review

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Biologics License Application (BLA) and granted Priority Review for the company’s product atezolizumab for the treatment of locally advanced or ... Read more